Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Journal of the American Heart Association
|
November 7, 2012
Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease
Parham Eshtehardi, Michael C McDaniel, Jin Suo, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 9, 2017
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Zhan Yang, Jin-Suo Chen, Jin-Kun Wen, et al.
Oncogene
|
December 12, 2018
Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway
Zhan Yang, Chang-Bao Qu, Yong Zhang, et al.
Journal of Medicinal Chemistry
|
April 26, 2019
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension
Zhen Wang, Xiangrui Jiang, Xianglei Zhang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Journal of the American Heart Association
|
November 7, 2012
Association of coronary wall shear stress with atherosclerotic plaque burden, composition, and distribution in patients with coronary artery disease
Parham Eshtehardi, Michael C McDaniel, Jin Suo, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 9, 2017
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Zhan Yang, Jin-Suo Chen, Jin-Kun Wen, et al.
Oncogene
|
December 12, 2018
Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway
Zhan Yang, Chang-Bao Qu, Yong Zhang, et al.
Journal of Medicinal Chemistry
|
April 26, 2019
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension
Zhen Wang, Xiangrui Jiang, Xianglei Zhang, et al.
Page
of 5